The Ultimate High-Yield Healthcare Stock to Buy With $10,000 Right Now
Healthcare's sleeping giant awakens—and it's paying investors to pay attention.
Forget chasing meme stocks and crypto hype cycles. This healthcare play delivers something Wall Street forgot exists: actual cash flow.
Dividend Dynamo Meets Medical Innovation
The company combines pharmaceutical stability with tech-driven growth—a rare hybrid in today's polarized market. While crypto bros stare at charts, this stock quietly compounds returns.
Why $10,000 Hits the Sweet Spot
That amount positions you for meaningful dividend reinvestment while leaving room for strategic averaging. Perfect for investors tired of 3 a.m. crypto margin calls.
Healthcare's Recession-Proof Edge
Patients need treatments in bull markets and bear markets. Unlike speculative assets, this company's revenue streams don't disappear when Bitcoin sneezes.
The Ultimate Contrarian Play
In a world obsessed with digital fairy tales, putting $10,000 into actual healthcare infrastructure feels almost rebellious. Your portfolio will thank you when the next 'de-fi summer' turns into crypto winter.
What does Intuitive Surgical do?
Intuitive Surgical makes the da Vinci surgical robot system. It was one of the first surgical robots on the market, and it is very popular. In the second quarter of 2025, da Vinci robots performed 17% more surgeries around the world than they did in the same quarter of 2024.
The healthcare company placed another 395 da Vinci robots into service in the quarter, as well, with nearly 10,500 working around the globe.

Image source: Getty Images.
What's interesting about the business model is that there are three sources of revenue. The first income stream is the sale of da Vinci surgical robots. But that's just the foundation, because those robots then need parts and service for as long as they are being used. In fact, at 60% of sales, selling instruments and accessories is actually the largest piece of the top line on Intuitive Surgical's income statement.
That shows the powerful recurring income that its installed base of robots can generate.
There's just one problem for dividend investors, given that Intuitive Surgical doesn't pay a dividend. It is a 100% growth story. But don't fret, if you like the growth story here and want some yield, too, you'll probably find(MDT 0.71%) very interesting.
What does Medtronic do?
Medtronic is, technically, a diversified medical device company, with operations in the cardiovascular, neuroscience, diabetes, and medical surgical niches. The company is planning to spin off its lower-margin diabetes division in 2026, so very shortly it will just have three divisions, making the medical surgical group even more important than it is today. This business generated $2 billion in sales in the fiscal first quarter of 2026, compared to the $2.4 billion in the comparable quarter for Intuitive Surgical.
To be fair, Medtronic's medical surgical division includes more than just surgical robots. But the company's Hugo surgical robot is starting to gain traction. And Medtronic is a valued partner for most major healthcare systems, meaning it has an in with customers as it looks to grow its installed robot base. That said, it is still early days for the Hugo system. But that could be seen as a positive, since it means there's an opportunity for rapid growth.
Meanwhile, the fact that surgical robots is just one piece of a more diversified business could also be seen as a further bonus for conservative investors. Whereas Intuitive Surgical lives and dies by the success of da Vinci, the introduction of Hugo is just one of many opportunities for Medtronic, which is also bringing out other new medical products, as well. Diversification helps to reduce risk in your portfolio and for companies.
The big Medtronic story is the dividend
That said, for dividend investors, the big story with Medtronic will be its lofty 3% dividend yield. That's well above the market's 1.2% yield, the 1.7% yield of the average healthcare stock, and infinitely more exciting than no yield, which is what you'll get with an investment in Intuitive Surgical.
And Medtronic's dividend has been increased annually for 48 consecutive years, which is just two years shy of Dividend King status. So, it not only offers a high yield, but it is also a reliable dividend payer.
There are usually more ways to invest in an idea than you may think. When it comes to surgical robots, the best direct play is probably Intuitive Surgical. But that doesn't mean it is the only choice. If you like dividends or just prefer not to go all in on surgical robots, diversified Medtronic is the high-yield alternative to Intuitive Surgical that you may have overlooked. And that could make it the ultimate high-yield healthcare stock for your portfolio today.